Spruce Share Price

Spruce Share Price

NASDAQ: SPRB | Micro Cap | Healthcare
$38.14
-$2.73 (-6.67%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Spruce Stock Performance

Open
$39.87
Prev. Close
$40.87
Circuit Range
N/A
Day Range
$38.41 - $39.87
Year Range
$38.21 - $109.97
Volume
1,627
Average Traded
$38.90

Spruce Share Price Today

As of 21 November 2026, Spruce Biosciences, Inc.'s share price is $38.14. The stock opened at $39.87, compared to its previous close of $40.87. During today's trading session, Spruce Biosciences, Inc.'s share price traded between $38.41 and $39.87, with an average price of $39.14. Over the past 52 weeks, the stock has recorded a high of $109.97 and a low of $38.21. In terms of performance, Spruce Biosciences, Inc.'s share price has declined by 22.83% over the last six months and is down 61.40% on a year-on-year basis.

Spruce Share Price Chart

Line chart of the Spruce price trend over the selected period. The price fell overall, ranging from 38.14 to 40.96, ending at 38.14.
$38.41$39.87
L
Show Current Price
H

Spruce Stock Fundamentals & Key Indicators

Market Cap
$29.24M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-23.36
Revenue (TTM)
$0.00
Return On Equity (TTM)
-101.29%
Profit Margin
N/A
Debt to Equity
0.12
Quarterly Earnings Growth YoY
-63.89%

Spruce Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$14.65-$12.27-$16.23-$24.01
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A16.25%-32.27%-47.94%

Spruce Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$10.09$4.91$0.00
Net Profit-$46.18-$47.92-$53.04-$38.97
Net Profit MarginN/A-474.93%-1080.24%N/A
Income ChangeN/A-3.77%-10.68%26.53%

Spruce Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets0.911.01.762.04
Current Assets52.1144.21102.1883.61
Total Assets53.0245.21103.9585.65
Non Current Liabilities0.421.142.974.72
Current Liabilities10.0915.2524.4712.45
Total Liabilities10.5116.3927.4417.16
Shareholders' Equity42.5228.8276.5168.49

Spruce Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-33.33-55.96-33.28-41.68
Investing0.00.055.7823.69
Financing43.48-1.6249.14-0.24

Corporate Actions

Split
Ex-date: 07 Aug 2025

About Spruce

Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company develops biologics and small-molecule product candidates aimed at addressing diseases with unmet medical needs and limited or no approved therapies. Its product candidate, TA-ERT for the treatment of Mucopolysaccharidosis Type IIIB (MPS IIIB), is a fusion protein comprised of recombinant human alpha-N-acetylglucosaminidase (rhNAGLU) intended as an enzyme replacement therapy for patients who lack rhNAGLU enzyme activity. TA-ERT is designed to restore rhNAGLU enzyme activity in the central nervous system following intracerebroventricular injection and promote clearance of heparan sulfate in the brain.

Spruce Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$45.07
$38.41
-16.02%
Oct 2026
$47.60
$45.74
-5.27%
Sep 2026
$55.81
$48.29
-21.96%
Aug 2026
$41.98
$61.88
+44.50%
Jul 2026
$51.69
$42.83
-21.90%
Jun 2026
$52.51
$54.84
+10.95%
May 2026
$58.25
$49.42
-13.23%
Apr 2026
$68.02
$56.96
-11.03%
Mar 2026
$53.36
$64.02
+8.01%
Feb 2026
$80.95
$59.27
-28.25%
Jan 2026
$83.02
$82.61
-2.17%
Dec 2025
$96.59
$84.44
-14.54%

Spruce Share Price FAQs